Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single-dose methotrexate: an expanded clinical trial

T G Stovall1, F W Ling

  • 1Department of Obstetrics and Gynecology, University of Tennessee, Memphis.

American Journal of Obstetrics and Gynecology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.

The Journal of reproductive medicine·2001
Same author

Nonsurgical treatment of ectopic pregnancy.

The New England journal of medicine·2000
Same author

Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices.

The Journal of clinical psychiatry·2000
Same author

A technique to reduce the chance of persistent ectopic pregnancy.

The Journal of the American Association of Gynecologic Laparoscopists·1999
Same author

Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.

The New England journal of medicine·1999
Same author

Primary care in obstetrics and gynecology resident education: a baseline survey of residents' perceptions and experiences.

Obstetrics and gynecology·1999
Same journal

Likelihood ratios enhance clinical interpretation of metagenomic prediction of early-onset neonatal sepsis in preterm premature rupture of membranes (Letter-to-the-Editor).

American journal of obstetrics and gynecology·2026
Same journal

Taking risk stratification in preterm premature rupture of membranes to the bedside (Reply to Letter-to-the-Editor).

American journal of obstetrics and gynecology·2026
Same journal

Gestational Age at Full-Term Delivery and Long-Term Offspring Morbidity in Low-Risk Pregnancies: A Population-Based Cohort Study.

American journal of obstetrics and gynecology·2026
Same journal

Trajectories of childbirth-related posttraumatic stress symptoms after a vaginal delivery: a multicenter prospective study.

American journal of obstetrics and gynecology·2026
Same journal

Early life adversity and polycystic ovary syndrome among North American pregnancy planners.

American journal of obstetrics and gynecology·2026
Same journal

Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer.

American journal of obstetrics and gynecology·2026
See all related articles

This study shows a nonlaparoscopic approach for ectopic pregnancy diagnosis and treatment with single-dose methotrexate is effective and safe, with high rates of future fertility and minimal follow-up needed.

Area of Science:

  • Reproductive Medicine
  • Gynecologic Surgery
  • Pharmacology

Background:

  • Ectopic pregnancy remains a significant concern in women's reproductive health.
  • Minimally invasive diagnostic and therapeutic strategies are crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate an expanded clinical trial using a nonlaparoscopic approach for ectopic pregnancy diagnosis.
  • To assess the efficacy and safety of single-dose intramuscular methotrexate treatment for ectopic pregnancy.

Main Methods:

  • A prospective cohort study enrolled 120 women with ectopic pregnancies (<= 3.5 cm).
  • Diagnosis involved transvaginal ultrasonography to visualize ectopic masses and cardiac activity.
  • Treatment consisted of single-dose intramuscular methotrexate.

Related Experiment Videos

Main Results:

  • The mean time to resolution was 35.5 days, with only 3.3% requiring a second dose.
  • No adverse biochemical or clinical side effects were reported.
  • Post-treatment, 82.3% showed tubal patency, and 79.6% of those attempting pregnancy conceived successfully.

Conclusions:

  • This nonlaparoscopic, single-dose methotrexate regimen is effective for treating unruptured ectopic pregnancies.
  • It simplifies treatment by requiring minimal laboratory follow-up and eliminating leukovorin recovery.
  • This approach is recommended as a primary medical treatment option for ectopic pregnancy.